Patient Access Liaison

Patient Access Liaison US Commercial, Market Access – Remote Pharvaris is a Nasdaq listed late-stage biotech company developing bradykinin B2 receptor antagonists for bradykinin-mediated angioedema (including hereditary angioedema), with offices in Switzerland (Zug), the Netherlands (Leiden) and the USA (greater Boston area). We aim at bringing new, more convenient options to people who suffer sudden and prolonged attacks of swelling in multiple areas of the body including the airway, which can…